Seasonal affective disorder (SAD) is a mood disorder subset in which people who have normal mental health throughout most of the year exhibit depressive symptoms at the same time each year, most commonly in the winter. Common symptoms include sleeping too much, having little to no energy, and overeating. The condition in the summer can include heightened anxiety._x000D_
Market Analysis and Insights: Global Seasonal Affective Disorder Therapeutics Market_x000D_
The global Seasonal Affective Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026._x000D_
Global Seasonal Affective Disorder Therapeutics Scope and Segment_x000D_
The global Seasonal Affective Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026._x000D_
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026._x000D_
By the type, the market is primarily split into_x000D_
Light Therapy (Phototherapy)_x000D_
Medication_x000D_
Others_x000D_
By the application, this report covers the following segments_x000D_
Hospitals_x000D_
Clinics_x000D_
Others_x000D_
Competitive Landscape:_x000D_
The Seasonal Affective Disorder Therapeutics key manufacturers in this market include:_x000D_
Allergan_x000D_
Pfizer_x000D_
Roche_x000D_
Eli Lily_x000D_
GlaxoSmithKline_x000D_
Teva Pharmaceuticals_x000D_
Bausch Health Companies_x000D_
Mylan_x000D_
Sanofi_x000D_
Novartis_x000D_
Johnson & Johnson_x000D_
Koninklijke Philips_x000D_
Beurer GmbH_x000D_
Lucimed (Luminette)
Market Analysis and Insights: Global Seasonal Affective Disorder Therapeutics Market_x000D_
The global Seasonal Affective Disorder Therapeutics market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026._x000D_
Global Seasonal Affective Disorder Therapeutics Scope and Segment_x000D_
The global Seasonal Affective Disorder Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Seasonal Affective Disorder Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type, and by Application for the period 2015-2026._x000D_
The major regions covered in the report are North America, Europe, China, Rest of Asia Pacific, Central & South America, Middle East & Africa, etc. It includes revenue analysis of each region for the year 2015 to 2026._x000D_
By the type, the market is primarily split into_x000D_
Light Therapy (Phototherapy)_x000D_
Medication_x000D_
Others_x000D_
By the application, this report covers the following segments_x000D_
Hospitals_x000D_
Clinics_x000D_
Others_x000D_
Competitive Landscape:_x000D_
The Seasonal Affective Disorder Therapeutics key manufacturers in this market include:_x000D_
Allergan_x000D_
Pfizer_x000D_
Roche_x000D_
Eli Lily_x000D_
GlaxoSmithKline_x000D_
Teva Pharmaceuticals_x000D_
Bausch Health Companies_x000D_
Mylan_x000D_
Sanofi_x000D_
Novartis_x000D_
Johnson & Johnson_x000D_
Koninklijke Philips_x000D_
Beurer GmbH_x000D_
Lucimed (Luminette)
1 Market Overview of Seasonal Affective Disorder Therapeutics
1.1 Seasonal Affective Disorder Therapeutics Market Overview
1.1.1 Seasonal Affective Disorder Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Seasonal Affective Disorder Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Seasonal Affective Disorder Therapeutics Market Size by Region (2015-2026)
1.4 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 China Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
2 Seasonal Affective Disorder Therapeutics Market Overview by Type
2.1 Global Seasonal Affective Disorder Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Light Therapy (Phototherapy)
2.5 Medication
2.6 Others
3 Seasonal Affective Disorder Therapeutics Market Overview by Application
3.1 Global Seasonal Affective Disorder Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Others
4 Global Seasonal Affective Disorder Therapeutics Competition Analysis by Players
4.1 Global Seasonal Affective Disorder Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Seasonal Affective Disorder Therapeutics Market
4.4 Global Top Players Seasonal Affective Disorder Therapeutics Headquarters and Area Served
4.5 Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Seasonal Affective Disorder Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business and Company’s Total Revenue
5.1.3 Allergan Products, Services and Solutions
5.1.4 Allergan Revenue (US$ Million) (2015-2020)
5.1.5 Allergan Recent Development and Reaction to Covid-19
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business and Company’s Total Revenue
5.2.3 Pfizer Products, Services and Solutions
5.2.4 Pfizer Revenue (US$ Million) (2015-2020)
5.2.5 Pfizer Recent Development and Reaction to Covid-19
5.3 Roche
5.5.1 Roche Profile
5.3.2 Roche Main Business and Company’s Total Revenue
5.3.3 Roche Products, Services and Solutions
5.3.4 Roche Revenue (US$ Million) (2015-2020)
5.3.5 Eli Lily Recent Development and Reaction to Covid-19
5.4 Eli Lily
5.4.1 Eli Lily Profile
5.4.2 Eli Lily Main Business and Company’s Total Revenue
5.4.3 Eli Lily Products, Services and Solutions
5.4.4 Eli Lily Revenue (US$ Million) (2015-2020)
5.4.5 Eli Lily Recent Development and Reaction to Covid-19
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business and Company’s Total Revenue
5.5.3 GlaxoSmithKline Products, Services and Solutions
5.5.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020)
5.5.5 GlaxoSmithKline Recent Development and Reaction to Covid-19
5.6 Teva Pharmaceuticals
5.6.1 Teva Pharmaceuticals Profile
5.6.2 Teva Pharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Teva Pharmaceuticals Products, Services and Solutions
5.6.4 Teva Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Teva Pharmaceuticals Recent Development and Reaction to Covid-19
5.7 Bausch Health Companies
5.7.1 Bausch Health Companies Profile
5.7.2 Bausch Health Companies Main Business and Company’s Total Revenue
5.7.3 Bausch Health Companies Products, Services and Solutions
5.7.4 Bausch Health Companies Revenue (US$ Million) (2015-2020)
5.7.5 Bausch Health Companies Recent Development and Reaction to Covid-19
5.8 Mylan
5.8.1 Mylan Profile
5.8.2 Mylan Main Business and Company’s Total Revenue
5.8.3 Mylan Products, Services and Solutions
5.8.4 Mylan Revenue (US$ Million) (2015-2020)
5.8.5 Mylan Recent Development and Reaction to Covid-19
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business and Company’s Total Revenue
5.9.3 Sanofi Products, Services and Solutions
5.9.4 Sanofi Revenue (US$ Million) (2015-2020)
5.9.5 Sanofi Recent Development and Reaction to Covid-19
5.10 Novartis
5.10.1 Novartis Profile
5.10.2 Novartis Main Business and Company’s Total Revenue
5.10.3 Novartis Products, Services and Solutions
5.10.4 Novartis Revenue (US$ Million) (2015-2020)
5.10.5 Novartis Recent Development and Reaction to Covid-19
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Profile
5.11.2 Johnson & Johnson Main Business and Company’s Total Revenue
5.11.3 Johnson & Johnson Products, Services and Solutions
5.11.4 Johnson & Johnson Revenue (US$ Million) (2015-2020)
5.11.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.12 Koninklijke Philips
5.12.1 Koninklijke Philips Profile
5.12.2 Koninklijke Philips Main Business and Company’s Total Revenue
5.12.3 Koninklijke Philips Products, Services and Solutions
5.12.4 Koninklijke Philips Revenue (US$ Million) (2015-2020)
5.12.5 Koninklijke Philips Recent Development and Reaction to Covid-19
5.13 Beurer GmbH
5.13.1 Beurer GmbH Profile
5.13.2 Beurer GmbH Main Business and Company’s Total Revenue
5.13.3 Beurer GmbH Products, Services and Solutions
5.13.4 Beurer GmbH Revenue (US$ Million) (2015-2020)
5.13.5 Beurer GmbH Recent Development and Reaction to Covid-19
5.14 Lucimed (Luminette)
5.14.1 Lucimed (Luminette) Profile
5.14.2 Lucimed (Luminette) Main Business and Company’s Total Revenue
5.14.3 Lucimed (Luminette) Products, Services and Solutions
5.14.4 Lucimed (Luminette) Revenue (US$ Million) (2015-2020)
5.14.5 Lucimed (Luminette) Recent Development and Reaction to Covid-19
6 North America Seasonal Affective Disorder Therapeutics by Players and by Application
6.1 North America Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
6.2 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
7 Europe Seasonal Affective Disorder Therapeutics by Players and by Application
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
8 China Seasonal Affective Disorder Therapeutics by Players and by Application
8.1 China Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
8.2 China Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics by Players and by Application
9.1 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
10 Latin America Seasonal Affective Disorder Therapeutics by Players and by Application
10.1 Latin America Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
11 Middle East & Africa Seasonal Affective Disorder Therapeutics by Players and by Application
11.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
12 Seasonal Affective Disorder Therapeutics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
1.1 Seasonal Affective Disorder Therapeutics Market Overview
1.1.1 Seasonal Affective Disorder Therapeutics Product Scope
1.1.2 Market Status and Outlook
1.2 Global Seasonal Affective Disorder Therapeutics Market Size Overview by Region 2015 VS 2020 VS 2026
1.3 Global Seasonal Affective Disorder Therapeutics Market Size by Region (2015-2026)
1.4 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Region (2015-2020)
1.5 Global Seasonal Affective Disorder Therapeutics Market Size Forecast by Region (2021-2026)
1.6 Key Regions, Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.1 North America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.2 Europe Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.3 China Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.4 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.5 Latin America Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
1.6.6 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size YoY Growth (2015-2026)
2 Seasonal Affective Disorder Therapeutics Market Overview by Type
2.1 Global Seasonal Affective Disorder Therapeutics Market Size by Type: 2015 VS 2020 VS 2026
2.2 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Type (2015-2020)
2.3 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Type (2021-2026)
2.4 Light Therapy (Phototherapy)
2.5 Medication
2.6 Others
3 Seasonal Affective Disorder Therapeutics Market Overview by Application
3.1 Global Seasonal Affective Disorder Therapeutics Market Size by Application: 2015 VS 2020 VS 2026
3.2 Global Seasonal Affective Disorder Therapeutics Historic Market Size by Application (2015-2020)
3.3 Global Seasonal Affective Disorder Therapeutics Forecasted Market Size by Application (2021-2026)
3.4 Hospitals
3.5 Clinics
3.6 Others
4 Global Seasonal Affective Disorder Therapeutics Competition Analysis by Players
4.1 Global Seasonal Affective Disorder Therapeutics Market Size (Million US$) by Players (2015-2020)
4.2 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Seasonal Affective Disorder Therapeutics as of 2019)
4.3 Date of Key Manufacturers Enter into Seasonal Affective Disorder Therapeutics Market
4.4 Global Top Players Seasonal Affective Disorder Therapeutics Headquarters and Area Served
4.5 Key Players Seasonal Affective Disorder Therapeutics Product Solution and Service
4.6 Competitive Status
4.6.1 Seasonal Affective Disorder Therapeutics Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles and Key Data
5.1 Allergan
5.1.1 Allergan Profile
5.1.2 Allergan Main Business and Company’s Total Revenue
5.1.3 Allergan Products, Services and Solutions
5.1.4 Allergan Revenue (US$ Million) (2015-2020)
5.1.5 Allergan Recent Development and Reaction to Covid-19
5.2 Pfizer
5.2.1 Pfizer Profile
5.2.2 Pfizer Main Business and Company’s Total Revenue
5.2.3 Pfizer Products, Services and Solutions
5.2.4 Pfizer Revenue (US$ Million) (2015-2020)
5.2.5 Pfizer Recent Development and Reaction to Covid-19
5.3 Roche
5.5.1 Roche Profile
5.3.2 Roche Main Business and Company’s Total Revenue
5.3.3 Roche Products, Services and Solutions
5.3.4 Roche Revenue (US$ Million) (2015-2020)
5.3.5 Eli Lily Recent Development and Reaction to Covid-19
5.4 Eli Lily
5.4.1 Eli Lily Profile
5.4.2 Eli Lily Main Business and Company’s Total Revenue
5.4.3 Eli Lily Products, Services and Solutions
5.4.4 Eli Lily Revenue (US$ Million) (2015-2020)
5.4.5 Eli Lily Recent Development and Reaction to Covid-19
5.5 GlaxoSmithKline
5.5.1 GlaxoSmithKline Profile
5.5.2 GlaxoSmithKline Main Business and Company’s Total Revenue
5.5.3 GlaxoSmithKline Products, Services and Solutions
5.5.4 GlaxoSmithKline Revenue (US$ Million) (2015-2020)
5.5.5 GlaxoSmithKline Recent Development and Reaction to Covid-19
5.6 Teva Pharmaceuticals
5.6.1 Teva Pharmaceuticals Profile
5.6.2 Teva Pharmaceuticals Main Business and Company’s Total Revenue
5.6.3 Teva Pharmaceuticals Products, Services and Solutions
5.6.4 Teva Pharmaceuticals Revenue (US$ Million) (2015-2020)
5.6.5 Teva Pharmaceuticals Recent Development and Reaction to Covid-19
5.7 Bausch Health Companies
5.7.1 Bausch Health Companies Profile
5.7.2 Bausch Health Companies Main Business and Company’s Total Revenue
5.7.3 Bausch Health Companies Products, Services and Solutions
5.7.4 Bausch Health Companies Revenue (US$ Million) (2015-2020)
5.7.5 Bausch Health Companies Recent Development and Reaction to Covid-19
5.8 Mylan
5.8.1 Mylan Profile
5.8.2 Mylan Main Business and Company’s Total Revenue
5.8.3 Mylan Products, Services and Solutions
5.8.4 Mylan Revenue (US$ Million) (2015-2020)
5.8.5 Mylan Recent Development and Reaction to Covid-19
5.9 Sanofi
5.9.1 Sanofi Profile
5.9.2 Sanofi Main Business and Company’s Total Revenue
5.9.3 Sanofi Products, Services and Solutions
5.9.4 Sanofi Revenue (US$ Million) (2015-2020)
5.9.5 Sanofi Recent Development and Reaction to Covid-19
5.10 Novartis
5.10.1 Novartis Profile
5.10.2 Novartis Main Business and Company’s Total Revenue
5.10.3 Novartis Products, Services and Solutions
5.10.4 Novartis Revenue (US$ Million) (2015-2020)
5.10.5 Novartis Recent Development and Reaction to Covid-19
5.11 Johnson & Johnson
5.11.1 Johnson & Johnson Profile
5.11.2 Johnson & Johnson Main Business and Company’s Total Revenue
5.11.3 Johnson & Johnson Products, Services and Solutions
5.11.4 Johnson & Johnson Revenue (US$ Million) (2015-2020)
5.11.5 Johnson & Johnson Recent Development and Reaction to Covid-19
5.12 Koninklijke Philips
5.12.1 Koninklijke Philips Profile
5.12.2 Koninklijke Philips Main Business and Company’s Total Revenue
5.12.3 Koninklijke Philips Products, Services and Solutions
5.12.4 Koninklijke Philips Revenue (US$ Million) (2015-2020)
5.12.5 Koninklijke Philips Recent Development and Reaction to Covid-19
5.13 Beurer GmbH
5.13.1 Beurer GmbH Profile
5.13.2 Beurer GmbH Main Business and Company’s Total Revenue
5.13.3 Beurer GmbH Products, Services and Solutions
5.13.4 Beurer GmbH Revenue (US$ Million) (2015-2020)
5.13.5 Beurer GmbH Recent Development and Reaction to Covid-19
5.14 Lucimed (Luminette)
5.14.1 Lucimed (Luminette) Profile
5.14.2 Lucimed (Luminette) Main Business and Company’s Total Revenue
5.14.3 Lucimed (Luminette) Products, Services and Solutions
5.14.4 Lucimed (Luminette) Revenue (US$ Million) (2015-2020)
5.14.5 Lucimed (Luminette) Recent Development and Reaction to Covid-19
6 North America Seasonal Affective Disorder Therapeutics by Players and by Application
6.1 North America Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
6.2 North America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
7 Europe Seasonal Affective Disorder Therapeutics by Players and by Application
7.1 Europe Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
7.2 Europe Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
8 China Seasonal Affective Disorder Therapeutics by Players and by Application
8.1 China Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
8.2 China Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
9 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics by Players and by Application
9.1 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
9.2 Rest of Asia Pacific Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
10 Latin America Seasonal Affective Disorder Therapeutics by Players and by Application
10.1 Latin America Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
10.2 Latin America Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
11 Middle East & Africa Seasonal Affective Disorder Therapeutics by Players and by Application
11.1 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size and Market Share by Players (2015-2020)
11.2 Middle East & Africa Seasonal Affective Disorder Therapeutics Market Size by Application (2015-2020)
12 Seasonal Affective Disorder Therapeutics Market Dynamics
12.1 Covid-19 Impact: Industry Trends
12.2 Covid-19 Impact: Market Drivers
12.3 Covid-19 Impact: Market Challenges
12.4 Porter’s Five Forces Analysis
13 Research Finding /Conclusion
14 Methodology and Data Source
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Disclaimer
14.4 Author List
